Back

Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Diagnosis and prognosis of HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Alexandros Briasoulis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

3 More presentations in this session

Presentation thumbnail
Differences in heart failure with preserved ejection fraction diagnostic and therapeutic practices between physicians from europe and the middle east and north africa: an international survey
Professor H. Alarfaj (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Miss A. Achten (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: the single centre experience
Assistant Professor M. Pandrc (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and prognosis of HFpEF

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Prevalence of frailty and standard geriatric syndromes in hospitalized patients with acute decompensated heart failure
thumbnail
Congress Presentation
Prevalence of frailty according to different domains in chronic heart failure
thumbnail
Congress Presentation
A comprehensive assessment of frailty in an advanced heart failure clinic: results of a prospective observational study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources